Spero Therapeutics, Inc

AVEO Pharmaceuticals Inc. is an oncology-focused biopharmaceutical company based in Cambridge, MA, dedicated to developing innovative medicines aimed at improving the lives of cancer patients. The company is committed to pursuing advanced solutions in cancer treatment through its research and development efforts. As part of its mission, AVEO emphasizes a culture of collaboration and innovation, working closely with partners and scientific advisors to enhance its therapeutic offerings. The company is driven by a passion for delivering better outcomes for patients facing the challenges of cancer. Generated from the website

Amgen is a global leader in biotechnology, dedicated to the development of innovative biologic medicines that address serious illnesses, particularly in areas with limited treatment options. The company's mission encompasses a commitment to scientific advancement, patient safety, and corporate responsibility, reflecting its core values of integrity and excellence. With a strong focus on research and development, Amgen employs cutting-edge technologies, including AI and data science, to optimize clinical trials and enhance drug design. The company also prioritizes community investment, diversity, and sustainability, striving to make a positive impact on healthcare access and health equity worldwide. Generated from the website

Alnylam Pharmaceuticals is a biopharmaceutical company. The company develops novel therapeutics based on the biological breakthrough known as ribonucleic acid interference. The company applies ribonucleic acid interference to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies. This discovery enables the creation of a broad new class of human therapeutics. Alnylam Pharmaceuticals maintains partnerships with leading pharmaceutical and medical technology companies to drive further developments and capabilities. Major alliances include Merck, Medtronic and Novartis. Alnylam Pharmaceuticals, founded in 2002, maintains global headquarters in Cambridge, Mass., and has an additional operating unit in Kulmbach, Germany.